Sekisui ChemicalSekisui Chemical Co.,Ltd.4204東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

Sekisui Chemical revenue and profit

Out of every ¥100 of sales, about ¥8 is left as operating profit. Revenue changed +0.9% from the prior year, operating profit -1.4%.

Five-year trend

Revenue¥1.31T
FY ending Mar 2022: ¥1.16T¥1.16TFY ending Mar 2023: ¥1.24T¥1.24TFY ending Mar 2024: ¥1.26T¥1.26TFY ending Mar 2025: ¥1.3T¥1.3TFY ending Mar 2026: ¥1.31T¥1.31TFY22FY23FY24FY25FY26
Operating income¥106.5B
FY ending Mar 2022: ¥88.9B¥88.9BFY ending Mar 2023: ¥91.7B¥91.7BFY ending Mar 2024: ¥94.4B¥94.4BFY ending Mar 2025: ¥108B¥108BFY ending Mar 2026: ¥106.5B¥106.5BFY22FY23FY24FY25FY26
Operating margin8.1%
FY ending Mar 2022: 7.7%7.7%FY ending Mar 2023: 7.4%7.4%FY ending Mar 2024: 7.5%7.5%FY ending Mar 2025: 8.3%8.3%FY ending Mar 2026: 8.1%8.1%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin5.7%
Asset turnover0.95×
ROA5.4%
ROA5.4%
Financial leverage1.96×
ROE10.7%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin5.7%
2022: 3.2%3.2%2023: 5.6%5.6%2024: 6.2%6.2%2025: 6.3%6.3%2026: 5.7%5.7%2223242526
Asset turnover0.95×
2022: 0.97×0.97×2023: 1.02×1.02×2024: 0.98×0.98×2025: 0.98×0.98×2026: 0.95×0.95×2223242526
ROA5.4%
2022: 3.1%3.1%2023: 5.7%5.7%2024: 6.1%6.1%2025: 6.2%6.2%2026: 5.4%5.4%2223242526
Financial leverage1.96×
2022: 1.96×1.96×2023: 1.95×1.95×2024: 1.97×1.97×2025: 1.95×1.95×2026: 1.96×1.96×2223242526
ROE10.7%
2022: 6.1%6.1%2023: 11.1%11.1%2024: 12.1%12.1%2025: 12.0%12.0%2026: 10.7%10.7%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20223.2%0.97×3.1%1.96×6.1%
20235.6%1.02×5.7%1.95×11.1%
20246.2%0.98×6.1%1.97×12.1%
20256.3%0.98×6.2%1.95×12.0%
20265.7%0.95×5.4%1.96×10.7%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue35.3%
2021: 33.3%33.3%2022: 31.5%31.5%2023: 30.4%30.4%2024: 31.2%31.2%2025: 31.1%31.1%2026: 35.3%35.3%212223242526
PPE ÷ total assets32.4%
2021: 30.6%30.6%2022: 30.5%30.5%2023: 30.7%30.7%2024: 29.7%29.7%2025: 30.3%30.3%2026: 32.4%32.4%212223242526
Goodwill ÷ parent equity1.0%
2021: 8.4%8.4%2022: 1.8%1.8%2023: 1.8%1.8%2024: 1.3%1.3%2025: 1.0%1.0%2026: 1.0%1.0%212223242526
Goodwill balance¥7.25B
2021: ¥50.9B¥50.9B2022: ¥10.7B¥10.7B2023: ¥11B¥11B2024: ¥8.64B¥8.64B2025: ¥6.87B¥6.87B2026: ¥7.25B¥7.25B212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥45.6B
2021: ¥35.1B¥35.1B2022: ¥37B¥37B2023: ¥40.5B¥40.5B2024: ¥41.7B¥41.7B2025: ¥44.2B¥44.2B2026: ¥45.6B¥45.6B212223242526
R&D / revenue3.5%
2021: 3.3%3.3%2022: 3.2%3.2%2023: 3.3%3.3%2024: 3.3%3.3%2025: 3.4%3.4%2026: 3.5%3.5%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue1,157,9451,242,5211,256,5381,297,7541,309,281
Cost of revenue801,994865,281864,343877,147885,102
Gross profit355,950377,240392,195420,606424,178
SG&A267,071285,574297,795312,655317,701
Operating income88,87991,66694,399107,951106,477
Pretax income69,85999,494111,479119,973105,023
Income tax31,09828,72632,42435,86727,671
Net income attributable to owners37,06769,26377,93081,92575,174
Operating margin7.7%7.4%7.5%8.3%8.1%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

6%
Property, plant and equipment 32%
5%
7%
Other assets 50%

Funding

8%
Other liabilities 30%
Equity 62%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥133.7B¥85.2B¥126.4B¥120.9B¥92.4B
Total assets¥1.2T¥1.23T¥1.32T¥1.33T¥1.43T
Net assets¥702.8B¥732.5B¥820.9B¥835.4B¥881.1B
Share capital¥100B¥100B¥100B¥100B¥100B
Property, plant and equipment¥365.3B¥377.4B¥392.5B¥403.9B¥462.6B
Intangible assets excluding goodwill¥46.7B¥51B¥59.1B¥59.1B¥57.6B
Goodwill¥10.7B¥11B¥8.64B¥6.87B¥7.25B
Investment securities¥130.7B¥137.3B¥127.4B¥105.1B¥101.6B
Current assets¥609.4B¥621.6B¥685.6B¥703.1B¥721.7B
Current liabilities¥329.7B¥328B¥344.6B¥340B¥388.6B
Short-term borrowings¥4.29B¥3.57B¥11.6B¥2.34B¥20B
Long-term borrowings¥58.1B¥56.2B¥46.3B¥46B¥41.2B
Bonds¥40B¥40B¥40B¥40B¥50B
Interest-bearing debt¥102.4Bderived¥99.8Bderived¥97.8Bderived¥88.4Bderived¥111.2Bderived
Total liabilities¥496.2B¥495.6B¥502.3B¥495.4B¥546.8B
Non-controlling interests¥28.1B¥27.5B¥28.6B¥28B¥29.9B
Equity attributable to owners of parent¥612.4B¥630B¥661.9B¥699.8B¥704.8B
Retained earnings¥448B¥468.1B¥501.9B¥544.8B¥558.2B
Treasury stock-¥44.6B-¥46.6B-¥48.7B-¥50.1B-¥58.7B

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第104期(2025/04/01-2026/03/31)

    ID S100YBAY2026-06-12Open
  • EDINET (FSA Japan)

    有価証券報告書-第103期(2024/04/01-2025/03/31)

    ID S100VXYE2025-06-16Open
  • EDINET (FSA Japan)

    有価証券報告書-第102期(2023/04/01-2024/03/31)

    ID S100TNOW2024-06-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2022/04/01-2023/03/31)

    ID S100R1O02023-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(令和3年4月1日-令和4年3月31日)

    ID S100OBGN2022-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(令和2年4月1日-令和3年3月31日)

    ID S100LMCU2021-06-23Open

Extracted from XBRL: 54 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.